| P50 | author | Kimikazu Yakushijin | Q91049097 |
| | Seiji Kakiuchi | Q95362367 |
| P2093 | author name string | Mitsuhiro Ito | |
| | Yasuyuki Saito | |
| | Katsuya Yamamoto | |
| | Yasuhiro Tanaka | |
| | Isaku Shinzato | |
| | Hironobu Minami | |
| | Akiko Hashimoto | |
| | Hiroshi Matsuoka | |
| | Yumiko Inui | |
| | Shinichiro Kawamoto | |
| | Keiichiro Uehara | |
| | Yoshiharu Miyata | |
| | Rina Sakai | |
| | Yu Mizutani | |
| | Hiroya Ichikawa | |
| | Keiji Kurata | |
| | Hirotaka Suto | |
| | Marika Okuni | |
| | Shigeki Nagao | |
| P2860 | cites work | Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients | Q33349390 |
| | Gemcitabine-based combination regimen in patients with peripheral T-cell lymphoma | Q33405000 |
| | Hepatosplenic gamma-delta T-cell lymphoma: clinicopathological features and treatment | Q33883235 |
| | Efficacy and safety of gemcitabine, carboplatin, dexamethasone, and rituximab in patients with relapsed/refractory lymphoma: a prospective multi-center phase II study by the Puget Sound Oncology Consortium | Q34477705 |
| | International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes | Q34594231 |
| | Hepatosplenic γδ T-cell lymphoma: an overview | Q38123327 |
| | Allogeneic and autologous stem cell transplantation for hepatosplenic T-cell lymphoma: a retrospective study of the EBMT Lymphoma Working Party | Q38252378 |
| | Prognostic Factors of Hepatosplenic T-cell Lymphoma: Clinicopathologic Study of 28 Cases | Q40001357 |
| | Outcomes of allogeneic stem cell transplantation in hepatosplenic T-cell lymphoma | Q43170191 |
| | Gemcitabine as single agent in pretreated T-cell lymphoma patients: evaluation of the long-term outcome. | Q43249154 |
| | Cell cycle effects of gemcitabine | Q43658876 |
| | Incidence, clinical findings, and survival of hepatosplenic T-cell lymphoma in the United States. | Q48160916 |
| P433 | issue | 5 | |
| P921 | main subject | hepatosplenic T-cell lymphoma | Q5731794 |
| | carboplatin | Q415588 |
| | dexamethasone | Q422252 |
| P304 | page(s) | 707-712 | |
| P577 | publication date | 2018-11-19 | |
| P1433 | published in | Internal Medicine | Q6047666 |
| P1476 | title | Successful Bridging Chemotherapy with Gemcitabine, Carboplatin, and Dexamethasone before Unrelated Stem Cell Transplantation for Hepatosplenic T-cell Lymphoma | |
| P478 | volume | 58 | |